Patents by Inventor G. Craig Hill

G. Craig Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130123175
    Abstract: The invention features compounds of the general formula: B-L-M where B is a binding agent capable of selectively binding to a nerve cell surface receptor and mediating absorption of the compound by the nerve cell; M is a moiety which performs a useful non-cytotoxic function when absorbed by a nerve cell, and can be a therapeutic moiety or an imaging moiety; and L is a linker coupling B to M. The invention also features methods of use of the compounds in, for example, treating conditions such as viral infections and pain, as well as in labeling nerve cells.
    Type: Application
    Filed: June 27, 2012
    Publication date: May 16, 2013
    Inventors: G. Craig Hill, Stephen B. Kahl, Robert R. Webb, Constance A. McKee
  • Patent number: 8232251
    Abstract: The invention features compounds of the general formula: B-L-M where B is a binding agent capable of selectively binding to a nerve cell surface receptor and mediating absorption of the compound by the nerve cell; M is a moiety which performs a useful non-cytotoxic function when absorbed by a nerve cell, and can be a therapeutic moiety or an imaging moiety; and L is a linker coupling B to M. The invention also features methods of use of the compounds in, for example, treating conditions such as viral infections and pain, as well as in labeling nerve cells.
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: July 31, 2012
    Assignee: Manzanita Pharmaceuticals, Inc.
    Inventors: G. Craig Hill, Stephen B. Kahl, Robert R. Webb, Constance A. McKee